is metformin a glp-1 receptor GLP1 Agonists—Effects beyond Obesity and Diabetes In a patient newly started

Another point to consider is that more weight loss is not necessarily better

You may not even know exactly what youre getting or whether the dose is accurate from one administration to the next. Indeed, GLP-1 use without medical oversight heightens the risk of medication side effects, such as gallbladder disease, pancreatitis, thyroid conditions, retinopathy and nutrient deficiencies

Thigh Lift or Lower Body Tightening In certain cases, smaller-scale procedures can tighten localized areas without requiring hospital care

Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases

The significant weight loss achieved with GLP-1 therapy varies by agent and dosewith semaglutide 2.4mg (Wegovy) achieving approximately 15% body weight reduction at 68 weeks, while liraglutide 3mg (Saxenda) typically produces 5-8% weight loss

Theyre doing fundamentally different things, and therefore have different results